.jpg;w=960)
A local researcher is hoping to hear from Flamborough residents interested in participating in a study aimed at helping people suffering from diabetic neuropathy.
According to Jiyeon Park, an MSc candidate in McMaster University’s Kinesiology program, the clinical research aims to “find a novel way to treat pain” in patients diagnosed with the condition. The study is being conducted at McMaster, and Park is collaborating with several doctors across Hamilton to recruit participants.
The purpose of the study is to investigate the effects of 10 days of brain stimulation on pain stimulation on pain symptoms.
“Participants will receive non-invasive brain stimulation called Transcranial Magnetic Stimulation (TMS),” explained Park. “This technique delivers magnetic pulses to the brain to alter pain perception with the goal of blocking pain signals. It is completely non-invasive and not painful.”
Park noted that TMS is currently approved for treating depression in Canada and research has shown its potential benefits for other neuropathic pain conditions as well. “This is why we are conducting the study to assess the effects of TMS on individuals with painful diabetic neuropathy,” Park said.
To be eligible for the study, applicants must be 20 to 80 years old, diagnosed with diabetic neuropathy and experiencing burning paint, persistent pain or painful sensation from touch.
The study will require 20 half-hour visits to McMaster over a three month period for the brain stimulation sessions, plus four, two-hour assessment sessions.
“I am particularly interested in connecting with people from Flamborough because I am also a resident of the area and I want my community to be informed about this research opportunity, which could benefit some individuals,” said Park in an email.
Participants will receive a parking pass or equivalent amount for transportation for each visit.
Park is hosting a Zoom meeting on Nov. 27 at 7:30 p.m. for those interested in learning more about the study. (Meeting ID: 962 3835 6301.)
Park is also available to answer questions about the study via email at [email protected].
